| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |